No results for ‘’
Kopran Ltd
₹235.26
(0.24%)
Wed, 16 Sept 2026, 07:55 am
Health Technology
Pharmaceuticals: Major
24.5KKopran Share Price Live Chart
1 Day
(0.24%)
No Result Found
Summary
Market Cap (in Cr)
996.37
Net Profit (in Cr)
38.55
P/B
1.63
Sector P/E
33.76
P/E
21.94
EV/EBITDA
12.58
Debt/Equity (Industry)
0.24
Interest Cover (Industry)
9.79
ROCE (Industry)
14.04
RONW (Industry)
13.17
ROE
7.64
ROCE
9.60
Debt/Equity
0.24
EPS (TTM)
5.33
Dividend Yield
0
Book Value
109.82
Interest Cover
6.56
Analysis
all
- Kopran is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Kopran is profitable, therefore cash runway is not a concern.
- Kopran is profitable, therefore cash runway is not a concern.
- Debt is well covered by operating cash flow (39.4%, greater than 20% of total debt).
- Debt is covered by short term assets, assets are 2.4x debt.
- Unable to evaluate Kopran's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
- Unable to evaluate Kopran's dividend against the top 25% market benchmark as the company has not reported any payouts.
- Kopran's level of debt (49%) compared to net worth is high (greater than 40%).
- High level of physical assets or inventory.
- The average tenure for the Kopran board of directors is less than 3 years, this suggests a new board.
Shareholding
| Shareholders | MAR 2026 | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 |
|---|---|---|---|---|---|
| Promoters | 44.42 | 44.42 | 44.42 | 44.42 | 44.42 |
| FII | 0.57 | 0.36 | 0.60 | 0.76 | 1.12 |
| DII | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public | 55.00 | 55.22 | 54.98 | 54.82 | 54.45 |
| Government | 0 | 0 | 0 | 0 | 0 |
Technical Analysis
Support and Resistance
| Type | R3 | R2 | R1 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 344.44 | 275.37 | 246.60 | 206.30 | 177.53 | 137.23 | 68.16 |
| Fibonacci | 275.37 | 248.99 | 232.68 | 206.30 | 179.92 | 163.61 | 137.23 |
| Camarilla | 236.82 | 230.49 | 224.16 | 206.30 | 211.50 | 205.17 | 198.84 |
Pivots Level: Classic
R3
+138.14
344.44
R2
+69.07
275.37
R1
+40.30
246.60
S1
-28.77
177.53
S2
-69.07
137.23
S3
-138.14
68.16
Moving Average
Period
Value
10-EMA
235.77
20-EMA
224.16
30-EMA
216.85
50-EMA
207.55
100-EMA
192.48
200-EMA
179.82
Corporate Actions
| Announcement Date | Purpose | Action | Ex Date |
|---|---|---|---|
| 19 May 2026 | board-meetings | Accounts, Quarterly Results, Dividend | |
| 30 Apr 2026 | egm | ||
| 22 Jan 2026 | board-meetings | Quarterly Results | |
| 12 Nov 2025 | board-meetings | Quarterly Results, Half Yearly Results | |
| 04 Aug 2025 | dividend | Final Dividend - Rs. - 3 | 04 Sept 2025 |
| 29 Jul 2025 | agm | ||
| 15 May 2025 | dividend | ₹3.00 Dividend /Share | 04 Sept 2025 |
| 19 Aug 2024 | agm | ||
| 02 Aug 2024 | dividend | Annual General Meeting/Dividend - Rs 3 Per Share | 03 Sept 2024 |
| 16 May 2024 | dividend | ₹3.00 Dividend /Share | 03 Sept 2024 |
Peer Comparison
Kopran Ltd
Cipla Ltd
Divis Laboratories Ltd
Dr Reddys Laboratories Ltd
Sun Pharmaceutical Industries Ltd
Torrent Pharmaceuticals Ltd
Kopran Ltd About
Kopran is engaged in the business of manufacturing of Formulation (Finished Dosage Form).
Industry
Pharmaceuticals - Indian - Bulk Drugs & Formln
Founded
1958
Headquarters
CEO
Susheel G Somani
Employees
Contact
Website
http://www.kopran.com
sunil@kopran.com
Phone
91-22-43661111
Location
Parijat House 1076, Dr E Moses Road Worli, Mumbai, Maharashtra, 400018
Kopran Ltd Company History
| Year | History |
|---|---|
| 2005 |
|
| 2006 |
|
| 2011 |
|
| 2013 |
|
| 2018 |
|
Deals
| Client Name | Deal Type | Order Side | QTY | Avg Price | Date |
|---|---|---|---|---|---|
| YUGA STOCKS AND COMMODITIES PRIVATE LIMITED | bulk | Buy | 265749 | 196.2 | 26 May 2026 |
| YUGA STOCKS AND COMMODITIES PRIVATE LIMITED | bulk | Sell | 682777 | 194.7 | 26 May 2026 |
| YUGA STOCKS AND COMMODITIES PRIVATE LIMITED | bulk | Buy | 2563633 | 192.84 | 25 May 2026 |
| NK SECURITIES RESEARCH PRIVATE LIMITED | bulk | Buy | 367795 | 188.01 | 25 May 2026 |
| YUGA STOCKS AND COMMODITIES PRIVATE LIMITED | bulk | Buy | 26700 | 192.62 | 25 May 2026 |
| YUGA STOCKS AND COMMODITIES PRIVATE LIMITED | bulk | Sell | 409820 | 195.8 | 25 May 2026 |
| SETU SECURITIES PVT LTD | bulk | Buy | 424276 | 195.81 | 25 May 2026 |
| ZAKI ABBAS NASSER | bulk | Buy | 400000 | 189.44 | 25 May 2026 |
| NEO APEX SHARE BROKING SERVICES LLP | bulk | Buy | 500027 | 188.63 | 25 May 2026 |
| SETU SECURITIES PVT LTD | bulk | Sell | 424276 | 193.99 | 25 May 2026 |
Frequently Asked Questions
1.What is the stock price of Kopran Ltd?
As of 16/09/2026 at 1:25 PM, Kopran Ltd shares are trading at ₹235.26.
2.What is the market cap. of Kopran Ltd?
As of 16/09/2026, the market capitalization of Kopran Ltd is ₹1,137.85 crore.
3.When was Kopran Ltd founded?
Kopran Ltd was founded in 1958.
4.What are the P/E and P/B ratios of Kopran Ltd?
As of 16/09/2026, Kopran Ltd has a P/E ratio of 45.47 and a P/B ratio of 1.63.
5.How can I buy shares of Kopran Ltd?
You can buy shares of Kopran Ltd through Pocketful. Simply open a Demat account, complete your KYC, add funds, and place a buy order.
6.What is the shareholding pattern of Kopran Ltd?
As of March,2026, promoters hold 44.42% in Kopran Ltd, while FIIs, DIIs and public shareholders hold 0.57%, 0.00% and 55.00%, respectively.
7.Does Kopran Ltd pay dividends?
Yes, Kopran Ltd pays dividends to eligible shareholders. The latest dividend announced by the company was ₹Final Dividend - Rs. - 3 per share.
8.What is the dividend yield of Kopran Ltd?
As of 16 September, 2026, the dividend yield of Kopran Ltd stands at 1.27%.
9.What are the latest financial results of Kopran Ltd?
For January,2024, Kopran Ltd reported revenue of ₹625.00 crore and a net profit of ₹38.55 crore.
10.What is the Stock symbol of Kopran Ltd?
KOPRAN is the stock symbol of Kopran Ltd.
11.Who is the CEO of Kopran Ltd?
The CEO of Kopran Ltd is Susheel G Somani.